Journal of the National Comprehensive Cancer Network : JNCCN

publication venue for

NCCN Guidelines Insights: Management of Immunotherapy-Related Toxicities, Version 1.2020. 2020
Management of Immunotherapy-Related Toxicities, Version 1.2019. 2019
Oncogenic Addiction to ERBB2 Signaling Predicts Response to Trastuzumab in Urothelial Cancer. 2019
NCCN Guidelines Insights: Thyroid Carcinoma, Version 2.2018. 2018
NCCN Guidelines Insights: Bladder Cancer, Version 5.2018. 2018
Merkel Cell Carcinoma, Version 1.2018, NCCN Clinical Practice Guidelines in Oncology. 2018
Lung Cancer Screening, Version 3.2018, NCCN Clinical Practice Guidelines in Oncology. 2018
NCCN Guidelines Insights: T-Cell Lymphomas, Version 2.2018. 2018
Bladder Cancer, Version 5.2017, NCCN Clinical Practice Guidelines in Oncology. 2017
NCCN Guidelines Insights: Myeloproliferative Neoplasms, Version 2.2018. 2017
Kidney Cancer, Version 2.2017, NCCN Clinical Practice Guidelines in Oncology. 2017
Hodgkin Lymphoma Version 1.2017, NCCN Clinical Practice Guidelines in Oncology. 2017
NCCN Guidelines Insights: Hepatobiliary Cancers, Version 1.2017. 2017
NCCN Guidelines Insights: Breast Cancer, Version 1.2017. 2017
Non-Small Cell Lung Cancer, Version 5.2017, NCCN Clinical Practice Guidelines in Oncology. 2017
Colon Cancer, Version 1.2017, NCCN Clinical Practice Guidelines in Oncology. 2017
NCCN Guidelines Insights: Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Version 1.2017. 2017
Multiple Myeloma, Version 3.2017, NCCN Clinical Practice Guidelines in Oncology. 2017
Vulvar Cancer, Version 1.2017, NCCN Clinical Practice Guidelines in Oncology. 2017
Myeloproliferative Neoplasms, Version 2.2017, NCCN Clinical Practice Guidelines in Oncology. 2016
NCCN Guidelines Insights: Older Adult Oncology, Version 2.2016. 2016
Gastric Cancer, Version 3.2016, NCCN Clinical Practice Guidelines in Oncology. 2016
NCCN Guidelines Insights: Bladder Cancer, Version 2.2016. 2016
NCCN Guidelines Insights: Non-Hodgkin's Lymphomas, Version 3.2016. 2016
Ovarian Cancer, Version 1.2016, NCCN Clinical Practice Guidelines in Oncology. 2016
Genetic/Familial High-Risk Assessment: Colorectal Version 1.2016, NCCN Clinical Practice Guidelines in Oncology. 2016
NCCN Guidelines Insights: Melanoma, Version 3.2016. 2016
NCCN Guidelines Insights: Malignant Pleural Mesothelioma, Version 3.2016. 2016
Prevention and Treatment of Cancer-Related Infections, Version 2.2016, NCCN Clinical Practice Guidelines in Oncology. 2016
NCCN Guidelines Insights: Survivorship, Version 1.2016. 2016
Basal Cell Skin Cancer, Version 1.2016, NCCN Clinical Practice Guidelines in Oncology. 2016
NCCN Guidelines Insights: Prostate Cancer Early Detection, Version 2.2016. 2016
Imatinib Treatment of Lymphangiomatosis (Generalized Lymphatic Anomaly). 2016
Melanoma, Version 2.2016, NCCN Clinical Practice Guidelines in Oncology. 2016
NCCN Guidelines Insights: Multiple Myeloma, Version 3.2016. 2016
Invasive Breast Cancer Version 1.2016, NCCN Clinical Practice Guidelines in Oncology. 2016
NCCN Clinical Practice Guidelines Prostate Cancer Early Detection, Version 2.2015. 2015
NCCN Guidelines Insights Breast Cancer, Version 1.2016. 2015
Multiple Myeloma, Version 2.2016: Clinical Practice Guidelines in Oncology. 2015
Uterine Sarcoma, Version 1.2016: Featured Updates to the NCCN Guidelines. 2015
Anaplastic Thyroid Carcinoma, Version 2.2015. 2015
Cancer-Related Fatigue, Version 2.2015. 2015
Colorectal Cancer Screening, Version 1.2015. 2015
Breast Cancer Risk Reduction, Version 2.2015. 2015
Hodgkin lymphoma, version 2.2015. 2015
Non-Small Cell Lung Cancer, Version 6.2015. 2015
Breast Cancer Version 2.2015. 2015
Chronic lymphocytic leukemia/small lymphocytic lymphoma, version 1.2015. 2015
Esophageal and esophagogastric junction cancers, version 1.2015. 2015
Kidney cancer, version 3.2015. 2015
Metastatic insulinoma: current molecular and cytotoxic therapeutic approaches for metastatic well-differentiated panNETs. 2015
Lung cancer screening, version 1.2015: featured updates to the NCCN guidelines. 2015
Neuroendocrine tumors, version 1.2015. 2015
Central nervous system cancers, version 2.2014. Featured updates to the NCCN Guidelines. 2014
Survivorship: screening for cancer and treatment effects, version 2.2014. 2014
Head and neck cancers, Version 2.2014. Clinical practice guidelines in oncology. 2014
Survivorship: nutrition and weight management, Version 2.2014. Clinical practice guidelines in oncology. 2014
Genetic/familial high-risk assessment: breast and ovarian, version 1.2014. 2014
Non-Hodgkin's lymphomas, version 4.2014. 2014
Prostate cancer early detection, version 1.2014. Featured updates to the NCCN Guidelines. 2014
Survivorship: healthy lifestyles, version 2.2014. 2014
Colon cancer, version 3.2014. 2014
Occult primary, version 3.2014. 2014
Survivorship: cognitive function, version 1.2014. 2014
Dermatofibrosarcoma protuberans, version 1.2014. 2014
Non-Hodgkin's lymphomas, version 2.2014. 2014
Survivorship: fatigue, version 1.2014. 2014
Melanoma, version 4.2014. 2014
Prostate cancer, version 2.2014. 2014
Survivorship: sleep disorders, version 1.2014. 2014
Breast cancer version 3.2014. 2014
Survivorship: pain version 1.2014. 2014
Cervical cancer screening. 2014
Merkel cell carcinoma, version 1.2014. 2014
Survivorship: sexual dysfunction (male), version 1.2013. 2014
Kidney cancer, version 2.2014. 2014
Survivorship: sexual dysfunction (female), version 1.2013. 2014
Uterine neoplasms, version 1.2014. 2014
Colorectal cancer screening. 2013
Prostate cancer, version 1.2014. 2013
Chronic Myelogenous Leukemia, Version 1.2014. 2013
Venous thromboembolic disease. 2013
Ovarian cancer, version 2.2013. 2013
Central nervous system cancers. 2013
Adult cancer pain. 2013
Head and neck cancers, version 2.2013. Featured updates to the NCCN guidelines. 2013
Breast cancer, version 3.2013: featured updates to the NCCN guidelines. 2013
Non-small cell lung cancer, version 2.2013. 2013
Gastric cancer, version 2.2013: featured updates to the NCCN Guidelines. 2013
Localized colon cancer, version 3.2013: featured updates to the NCCN Guidelines. 2013
Penile cancer: Clinical Practice Guidelines in Oncology. 2013
Thymomas and thymic carcinomas: Clinical Practice Guidelines in Oncology. 2013
Bladder cancer. 2013
Melanoma, version 2.2013: featured updates to the NCCN guidelines. 2013
Cervical cancer. 2013
Non-Hodgkin's lymphomas, version 1.2013. 2013
Small cell lung cancer. 2013
Ovarian cancer, version 3.2012. 2012
Prevention and treatment of cancer-related infections. 2012
Non-small cell lung cancer. 2012
Waldenström's macroglobulinemia/lymphoplasmacytic lymphoma, version 2.2013. 2012
Prostate cancer, Version 3.2012: featured updates to the NCCN guidelines. 2012
Acute lymphoblastic leukemia. 2012
Metastatic breast cancer, version 1.2012: featured updates to the NCCN guidelines. 2012
Neuroendocrine tumors. 2012
Hodgkin lymphoma, version 2.2012 featured updates to the NCCN guidelines. 2012
Anal Carcinoma, Version 2.2012: featured updates to the NCCN guidelines. 2012
Antiemesis. 2012
Testicular cancer. 2012
Dermatofibrosarcoma protuberans. 2012
Melanoma. 2012
Mucosal melanoma of the head and neck. 2012
Lung cancer screening. 2012
Senior adult oncology. 2012
Chronic myelogenous leukemia. 2012
Malignant pleural mesothelioma. 2012
NCCN Clinical Practice Guidelines Occult primary. 2011
NCCN molecular testing white paper: effectiveness, efficiency, and reimbursement. 2011
Colon cancer. 2011
Multiple myeloma. 2011
Small cell lung cancer. 2011
Hodgkin lymphoma. 2011
Kidney cancer. 2011
Esophageal and esophagogastric junction cancers. 2011
Venous thromboembolic disease. 2011
Head and neck cancers. 2011
Non-Hodgkin's lymphomas. 2011
Central nervous system cancers. 2011
Acute myeloid leukemia. 2011
Invasive breast cancer. 2011
Epithelial ovarian cancer. 2011
Cervical cancer screening. 2010
Cervical cancer. 2010
Thymic malignancies. 2010
Thyroid carcinoma. 2010
Breast cancer risk reduction. 2010
Breast cancer: noninvasive and special situations. 2010
Adult cancer pain. 2010
Basal cell and squamous cell skin cancers. 2010
NCCN Clinical Practice Guidelines Cancer-related fatigue. 2010
Modification and implementation of NCCN guidelines on lymphomas in the Middle East and North Africa region. 2010
Genetic/familial high-risk assessment: breast and ovarian. 2010
Medullary carcinoma. 2010
Distress management. 2010
Gastric cancer. 2010
NCCN Clinical Practice Guidelines in Oncology: non-Hodgkin's lymphomas. 2010
NCCN clinical practice guidelines in oncology: prostate cancer. 2010
NCCN clinical practice guidelines in oncology. Anal carcinoma. 2010
NCCN clinical practice guidelines in oncology. Colorectal cancer screening. 2010
NCCN clinical practice guidelines in oncology: breast cancer screening and diagnosis. 2009
NCCN clinical practice guidelines in oncology: chronic myelogenous leukemia. 2009
NCCN clinical practice guidelines in oncology: multiple myeloma. 2009
NCCN Clinical Practice Guidelines in Oncology: colon cancer. 2009
NCCN Clinical Practice Guidelines in Oncology: rectal cancer. 2009
NCCN Clinical Practice Guidelines in Oncology: neuroendocrine tumors. 2009
NCCN clinical practice guidelines in oncology: kidney cancer. 2009
NCCN clinical practice guidelines in oncology: testicular cancer. 2009
NCCN clinical practice guidelines in oncology: hepatobiliary cancers. 2009
Melanoma. 2009
Merkel cell carcinoma. 2009
Breast cancer. Clinical practice guidelines in oncology. 2009
Esophageal cancer. 2008
Ovarian cancer. Clinical practice guidelines in oncology. 2008
Venous thromboembolic disease. NCCN. Clinical practice guidelines in oncology. 2008
Head and neck cancers. 2008
Cancer- and chemotherapy-induced anemia. 2008
Hodgkin disease/lymphoma. 2008
Central nervous system cancers. 2008
Non-Hodgkin's lymphomas. 2008
Non-small cell lung cancer. 2008
Prevention and treatment of cancer-related infections. 2008
Cancer-related fatigue. Clinical Practice Guidelines in Oncology. 2007
Colon cancer. 2007
Rectal cancer. 2007
Prostate cancer. Clinical practice guidelines in oncology. 2007
Thyroid carcinoma. 2007
Basal cell and squamous cell skin cancers. 2007
Chronic myelogenous leukemia. 2007
Dermatofibrosarcoma protuberans. 2007
Bone cancer. 2007
Multiple myeloma. Clinical practice guidelines in oncology. 2007
Antiemesis. 2007
Distress management. 2007
Bladder cancer. Clinical guidelines in oncology. 2006
Kidney cancer. Clinical practice guidelines in oncology. 2006
Testicular cancer. Clinical practice guidelines in oncology. 2006
Ovarian cancer. Clinical practice guidelines in oncology. 2006
Venous thromboembolic disease. Clinical practice guidelines in oncology. 2006
Melanoma. 2006
Merkel cell carcinoma. 2006
Non-small cell lung cancer clinical practice guidelines in oncology. 2006
Small cell lung cancer clinical practice guidelines in oncology. 2006
Uterine cancers. 2006
Colorectal Cancer Screening Clinical Practice Guidelines. 2006
Esophageal Cancer Clinical Practice Guidelines. 2006
Gastric Cancer Clinical Practice Guidelines. 2006
Hodgkin disease/lymphoma. Clinical practice guidelines in oncology. 2006
Non-Hodgkin's lymphoma. Clinical practice guidelines in oncology. 2006
Acute myeloid leukemia clinical practice guidelines in oncology. 2006
Central nervous system cancers: Clinical Practice Guidelines in Oncology. 2005
Anal canal cancer clinical practice guidelines in oncology. 2005
Colon cancer clinical practice guidelines in oncology. 2005
Rectal cancer clinical practice guidelines in oncology. 2005
Breast cancer. 2005
Head and neck cancers. 2005
Thyroid carcinoma. 2005
Bone cancer clinical practice guidelines. 2005
Occult primary cancer clinical practice guidelines. 2005
Bladder cancer. Clinical practice guidelines in oncology. 2005
Kidney cancer. Clinical practice guidelines. 2005
Testicular cancer. Clinical practice guidelines. 2005
Cervical cancer guidelines. Clinical practice guidelines in oncology. 2004
Cervical cancer screening clinical practice guidelines in oncology. 2004
Ovarian cancer clinical practice guidelines. 2004
Antiemesis clinical practice guidelines in oncology. 2004
Fever and neutropenia clinical practice guidelines. 2004
Non-Hodgkin's lymphoma clinical practice guidelines. 2004
Anal canal cancer. Clinical practice guidelines in oncology. 2003
Anemia clinical practice guidelines in oncology. 2003
Colon cancer. Clinical practice guidelines in oncology. 2003
Rectal cancer. Clinical practice guidelines in oncology. 2003
Immune-Related Adverse Events Among COVID-19-Vaccinated Patients With Cancer Receiving Immune Checkpoint Blockade.. 20. 2022
Sex- and Age-Related Differences in the Distribution of Metastases in Patients With Upper Urinary Tract Urothelial Carcinoma.. 19. 2021
Prostate Cancer Grade and Stage Misclassification in Active Surveillance Candidates: Black Versus White Patients.. 18. 2020
Small Renal Masses With Tumor Size 0 to 2 cm: A SEER-Based Study and Validation of NCCN Guidelines.. 18. 2020
Conditional Survival of Patients With Nonmetastatic Renal Cell Carcinoma: How Cancer-Specific Mortality Changes After Nephrectomy.. 18. 2020
Trends and Social Barriers for Inpatient Palliative Care in Patients With Metastatic Bladder Cancer Receiving Critical Care Therapies.. 17. 2019
Antimicrobial Stewardship in Cancer Patients: The Time is Now.. 17. 2019
Geriatric Assessment, Not ASA Physical Status, Is Associated With 6-Month Postoperative Survival in Patients With Cancer Aged ≥75 Years.. 17. 2019
Nonmelanoma Skin Cancer in Childhood and Young Adult Cancer Survivors Previously Treated With Radiotherapy.. 17. 2019
Tumor Board Conferences for Multidisciplinary Skin Cancer Management: A Survey of US Cancer Centers.. 16. 2018
Clinical and Genetic Risk Factors for Adverse Metabolic Outcomes in North American Testicular Cancer Survivors.. 16. 2018
Frequency, Morbidity, and Mortality of Bone Metastases in Advanced Hepatocellular Carcinoma.. 16. 2018
Myeloid Growth Factors, Version 2.2017, NCCN Clinical Practice Guidelines in Oncology.. 15. 2017
Electronic Rapid Fitness Assessment: A Novel Tool for Preoperative Evaluation of the Geriatric Oncology Patient.. 15. 2017
NCCN Guidelines Insights: Genetic/Familial High-Risk Assessment: Breast and Ovarian, Version 2.2017.. 15. 2017
NCCN Guidelines Insights: Chronic Myeloid Leukemia, Version 1.2017.. 14. 2016
Neoadjuvant Therapy for Rectal Cancer Affects Lymph Node Yield and Status Without Clear Implications on Outcome: The Case for Eliminating a Metric and Using Preoperative Staging to Guide Therapy.. 14. 2016
High Body Mass Index in Elderly Patients With DLBCL Treated With Rituximab-Containing Therapy Compensates for Negative Impact of Male Sex.. 14. 2016
Whole-Exome Sequencing in Two Extreme Phenotypes of Response to VEGF-Targeted Therapies in Patients With Metastatic Clear Cell Renal Cell Carcinoma.. 14. 2016
The Role of Biosimilars.. 14. 2016
NCCN Guidelines Insights: Non-Small Cell Lung Cancer, Version 4.2016.. 14. 2016
Diffuse Large B-Cell Lymphoma Version 1.2016.. 14. 2016
Genetic/Familial High-Risk Assessment: Breast and Ovarian, Version 2.2015.. 14. 2016
Acute Lymphoblastic Leukemia, Version 2.2015.. 13. 2015
Anemia and Functional Disability in Older Adults With Cancer.. 13. 2015
Central Nervous System Cancers, Version 1.2015.. 13. 2015
The Right Drug for the Right Patient: Navigating Systemic Therapy Options in Metastatic Renal Cell Carcinoma and Future Directions.. 13. 2015
Head and Neck Cancers, Version 1.2015.. 13. 2015
Rectal Cancer, Version 2.2015.. 13. 2015
Testicular Cancer, Version 2.2015.. 13. 2015
Emerging treatment options for B-cell lymphomas.. 13. 2015
Management of dermatologic toxicities.. 13. 2015
NCCN Roundtable: What Are the Characteristics of an Optimal Clinical Practice Guideline?. 13. 2015
Cervical Cancer, Version 2.2015.. 13. 2015
Cost implications and complications of overtreatment of low-risk prostate cancer in the United States.. 13. 2015
Guideline familiarity predicts variation in self-reported use of routine surveillance PET/CT by physicians who treat head and neck cancer.. 13. 2015
Diet and physical activity in the prevention of colorectal cancer.. 12. 2014
Non-small cell lung cancer, version 1.2015.. 12. 2014
Thyroid carcinoma, version 2.2014.. 12. 2014
Chronic myelogenous leukemia, version 1.2015.. 12. 2014
Where exactly does ponatinib fit in chronic myelogenous leukemia?. 12. 2014
Hepatobiliary cancers, version 2.2014.. 12. 2014
Survivorship: immunizations and prevention of infections, version 2.2014.. 12. 2014
Systemic therapy for advanced appendiceal adenocarcinoma: an analysis from the NCCN Oncology Outcomes Database for colorectal cancer.. 12. 2014
False-positive elevations of carcinoembryonic antigen in patients with a history of resected colorectal cancer.. 12. 2014
Neoadjuvant chemotherapy first, followed by chemoradiation and then surgery, in the management of locally advanced rectal cancer.. 12. 2014
Neoadjuvant radiotherapy use in locally advanced rectal cancer at NCCN member institutions.. 12. 2014
Senior adult oncology, version 2.2014: clinical practice guidelines in oncology .. 12. 2014
Survivorship: introduction and definition. Clinical practice guidelines in oncology.. 12. 2014
Study using the NCCN guidelines for palliative care to screen patients for palliative care needs and referral to palliative care specialists.. 11. 2013
Metastatic colon cancer, version 3.2013: featured updates to the NCCN Guidelines.. 11. 2013
Second-generation epidermal growth factor receptor tyrosine kinase inhibitors in lung cancers.. 11. 2013
Multiple myeloma, version 1.2013.. 11. 2013
Non-Hodgkin's Lymphomas, version 3.2012.. 10. 2012
Rectal cancer.. 10. 2012
A randomized phase II study of cetuximab every 2 weeks at either 500 or 750 mg/m2 for patients with recurrent or metastatic head and neck squamous cell cancer.. 10. 2012
BRAF mutations in colorectal cancer: clinical relevance and role in targeted therapy.. 10. 2012
Hypofractionated whole breast radiation and partial breast radiation for early-stage breast cancers: an update on progress.. 10. 2012
Ten years of progress in renal cell carcinoma.. 10. 2012
Modern approaches to localized cancer of the esophagus.. 9. 2011
Identifying older patients with acute myeloid leukemia who may be candidates for reduced-intensity hematopoietic cell transplantation.. 9. 2011
NCCN Task Force report: optimizing treatment of advanced renal cell carcinoma with molecular targeted therapy.. 9 Suppl 1. 2011
NCCN Task Force report: tyrosine kinase inhibitor therapy selection in the management of patients with chronic myelogenous leukemia.. 9 Suppl 2. 2011
Fertility-sparing surgery in early-stage cervical cancer: indications and applications.. 8. 2010
Chronic pain management in cancer survivors.. 8. 2010
Complications of multiple myeloma therapy, part 2: risk reduction and management of venous thromboembolism, osteonecrosis of the jaw, renal complications, and anemia.. 8 Suppl 1. 2010
Concordance with NCCN Colorectal Cancer Guidelines and ASCO/NCCN Quality Measures: an NCCN institutional analysis.. 7. 2009
Small cell lung cancer.. 6. 2008
Point: combination versus single-agent chemotherapy: the argument for sequential single agents.. 5. 2007
NCCN task force report: positron emission tomography (PET)/computed tomography (CT) scanning in cancer.. 5 Suppl 1. 2007
Cancer- and treatment-related anemia.. 3. 2005
Chronic myelogenous leukemia.. 3. 2005
New approaches in the management of lung cancer.. 3 Suppl 1. 2005
Proteasome inhibitors in non-Hodgkin's lymphoma.. 3 Suppl 1. 2005
Update: NCCN breast cancer Clinical Practice Guidelines.. 3 Suppl 1. 2005
Update: NCCN prostate cancer Clinical Practice Guidelines.. 3 Suppl 1. 2005
Promising activity of the proteasome inhibitor bortezomib (VELCADE) in the treatment of indolent non-Hodgkin's lymphoma and mantle cell lymphoma: ASH poster session 517-II.. 2 Suppl 4. 2004
Innovations in the treatment of melanoma.. 2 Suppl 3. 2004
New advances in taxane therapy: the next generation.. 2 Suppl 3. 2004
New advances in the treatment of gastric cancer.. 2 Suppl 3. 2004
Update: NCCN non-small cell lung cancer clinical practice guidelines.. 2 Suppl 3. 2004
Counterpoint: The case against adjuvant high-dose interferon-alpha for melanoma patients.. 2. 2004
Prostate cancer: nomograms and risk assessment models.. 1 Suppl 3. 2003
Update: colorectal cancer guidelines.. 1 Suppl 3. 2003
Psychological issues in geriatric oncology.. 1. 2003
Counterpoint: Prostate-specific antigen velocity is not of value for early detection of cancer. 2013
Counterpoint: Hyperthermia with radiation therapy for chest wall recurrences. 2007
Geriatric Oncology Education for the Oncologist is Overdue. 2018
Evaluating the potential role of PET/CT in the posttreatment surveillance of head and neck cancer. 2015
NCCN Biosimilars White Paper: regulatory, scientific, and patient safety perspectives. 2011
NCCN Task Force Report: Bone Health in Cancer Care. 2009
Antiemesis. Clinical Practice Guidelines in Oncology. 2009
Uterine Neoplasms. Clinical Practice Guidelines in Oncology. 2009
Bladder cancer. 2009
Cervical cancer screening. 2008
Cervical cancer. 2008
Breast cancer risk reduction. 2007
NCCN Task Force Report: Bone Health and Cancer Care. 2006
Genetic/familial high-risk assessment: breast and ovarian. 2006
Neuroendocrine tumors. 2006
NCCN Guidelines and Quality Cancer Care: Where Have We Come From, and Where Should We Be Going?. 14. 2016
Guidelines for NHL: updates to the management of diffuse large B-cell lymphoma and new guidelines for primary cutaneous CD30+ T-cell lymphoproliferative disorders and T-cell large granular lymphocytic leukemia.. 12. 2014
International adaptation and use of NCCN Guidelines.. 12. 2014
NCCN bone health task force: key recommendations.. 12. 2014
Point/Counterpoint: early detection of prostate cancer: do the benefits outweigh the consequences?. 12. 2014
Primary Mediastinal B-Cell Lymphoma in Children and Young Adults. 2023
Management of Immunotherapy-Related Toxicities, Version 1.2022, NCCN Clinical Practice Guidelines in Oncology. 2022
The Future of Parallel Tumor and Germline Genetic Testing: Is There a Role for All Patients With Cancer? 2021
Role of Immunotherapy in the Management of Locally Advanced and Recurrent/Metastatic Cervical Cancer. 2019
Evolving Roles of Histologic Evaluation and Molecular/Genomic Profiling in the Management of Endometrial Cancer. 2018
Emerging Role of CAR T Cells in Non-Hodgkin's Lymphoma. 2017
Role of Repeat Resection in Non-Muscle-Invasive Bladder Cancer. 2015
Follow-Up Management of Patients With Testicular Cancer: A Multidisciplinary Consensus-Based Approach. 2015
Spine Radiosurgery in the Management of Renal Cell Carcinoma Metastases. 2015
Historical views, conventional approaches, and evolving management strategies for myeloproliferative neoplasms. 2015
Pertuzumab in the treatment of HER2+ breast cancer. 2014
Sentinel lymph node mapping for endometrial cancer: a modern approach to surgical staging. 2014
Translating genomics in cancer care. 2013
NCCN Task Force Report: Bone Health In Cancer Care. 2013
Systemic therapy for small cell lung cancer. 2013
Progress in the management of melanoma in 2013. 2013
Recent advances in the treatment of non-Hodgkin's lymphomas. 2013
Systemic therapy for metastatic colorectal cancer. 2013
Distress management. 2013
Impact of the 7th Edition AJCC staging classification on the NCCN clinical practice guidelines in oncology for gastric and esophageal cancers. 2013
Exocrine pancreas cancer and thromboembolic events: a systematic literature review. 2012
Systemic therapy for advanced pancreatic neuroendocrine tumors: an update. 2012
The management of patients with stage IIIA non-small cell lung cancer with N2 mediastinal node involvement. 2012
Late cardiovascular toxicity following chemotherapy for germ cell tumors. 2012
Controversies in the management of regional nodes in melanoma. 2012
Novel therapies in phase II and III trials for malignant pleural mesothelioma. 2012
Surgery for early-stage small cell lung cancer. 2011
Current recommendations for systemic therapy of recurrent and/or metastatic head and neck squamous cell cancer. 2011
A review of VEGF/VEGFR-targeted therapeutics for recurrent glioblastoma. 2011
Inflammatory breast cancer. 2011
Psychostimulants for cancer-related fatigue. 2010
Non-small cell lung cancer. 2010
Gastric cancer: a primer on the epidemiology and biology of the disease and an overview of the medical management of advanced disease. 2010
An update on the role of interim restaging FDG-PET in patients with diffuse large B-cell lymphoma and Hodgkin lymphoma. 2010
NCCN task force report: management of neuropathy in cancer. 2009
NCCN task force report: molecular markers in leukemias and lymphomas. 2009
NCCN task force: clinical utility of PET in a variety of tumor types. 2009
NCCN Task Force Report: Management of dermatologic and other toxicities associated with EGFR inhibition in patients with cancer. 2009
Selection of patients with hepatocellular carcinoma for sorafenib. 2009
Integrating perioperative chemotherapy into the treatment of muscle-invasive bladder cancer: strategy versus reality. 2009
Acute myeloid leukemia. 2008
Occult primary. 2008
Strategy for incorporating molecular and cytogenetic markers into acute myeloid leukemia therapy. 2008
Therapy for older AML patients: the role of novel agents and allogeneic stem cell transplant. 2008
The role of inhibitors of the epidermal growth factor in management of head and neck cancer. 2008
Review of the treatment of mycosis fungoides and sézary syndrome: a stage-based approach. 2008
NCCN Task Force Report: Oral chemotherapy. 2008
NCCN Task Force Report. prevention and management of mucositis in cancer care. 2008
NCCN Task Force Report: breast cancer in the older woman. 2008
Update on psychotropic medications for cancer-related fatigue. 2007
Targeted strategies in the treatment of metastatic colon cancer. 2007
Investigational therapies for metastatic thyroid carcinoma. 2007
Invasive breast cancer. 2007
Importance of node dissection in relation to neoadjuvant and adjuvant therapy. 2006
Role of dermatologists in treating melanoma. 2006
Pulmonary neuroendocrine tumors: What (little) do we know? 2006
Favorable early-stage Hodgkin lymphoma. 2006
Partial-breast radiation for early staged breast cancers: hypothesis, existing data, and a planned phase III trial. 2005
Elucidation of the molecular mechanisms of malignant bone tumors: refining diagnosis and identifying novel targets for treatment. 2005
The integration of chemotherapy and surgery for bladder cancer. 2005
Surgery in the management of small cell lung cancer. 2004
Point: sentinel lymph node biopsy is indicated for patients with DCIS. 2003
Controversies in the surgical management of gastric cancer. 2003

VIVO Weill Cornell Medical College

Journal of the National Comprehensive Cancer Network : JNCCN Journal

Overview

publication venue for

Identity

ISO Abbreviation

Linking ISSN

International Standard Serial Number (ISSN)

Electronic International Standard Serial Number (EISSN)